(University of Vermont College of Medicine) In rural states like Vermont, opioid-dependent adults desperate for treatment often find themselves stuck on a wait list, sometimes for eight months or more, increasing their risk of continuing to use illicit opioids, contract an infectious disease, overdose and prematurely die. Stacey Sigmon, Ph.D., an addiction research expert with the Vermont Center on Behavior and Health, has developed an "Interim Buprenorphine Treatment" regimen for waitlisted opioid-dependent adults. Results debut in New England Journal of Medicine.
from EurekAlert! - Social and Behavioral Science http://ift.tt/2i2l6fA
No comments:
Post a Comment